Caffeine

Introduction to Caffeine

  • Caffeine is a methylxanthine, an alkaloid from plant origins.

  • Other methylxanthines include theophylline and theobromine.

Caffeine Sources

  • Common sources include coffee, tea, and chocolate with varying caffeine concentrations.

Caffeine Consumption

  • Estimated average global consumption: ~70 mg/day.

  • US average: nearly 170 mg/day, rising to 186 mg/day.

  • 90% of the population consumes caffeine products.

Pharmacology of Caffeine

  • Mechanisms of action:

    • Inhibition of phosphodiesterase.

    • Release of calcium from stores.

    • Antagonism of adenosine receptors (primary action).

  • Caffeine leads to increased dopamine levels but may impact receptor efficiency at high doses.

Pharmacokinetics

  • Absorption: Rapid, peak concentrations in 15-45 minutes.

  • Distribution: Uniform throughout the body.

  • Metabolism: Primarily in the liver; excreted mostly by kidneys.

Tolerance and Dependence

  • Tolerance develops, especially for physiological effects (renal, sleep, etc.), less for stimulant effects.

  • Withdrawal symptoms commonly include headache and fatigue.

Acute Effects

  • Behavioral effects: Increased energy, alertness, and mood elevation.

  • Can impair decision-making despite increased motor performance.

Interactions with Other Substances

  • Caffeine, nicotine, and alcohol commonly used together.

  • Can mask alcohol's effects, may lead to binge drinking.

Acute Toxicity

  • Symptoms can occur from as little as 250 mg of caffeine.

  • Risk increases above 1,000 mg.

  • Lethal dose estimated around 10 grams (approximately 75 cups of coffee).

Chronic Effects

  • Low to moderate caffeine intake shown not to affect reproduction or significant health outcomes.

  • Potential benefits include prevention of certain diseases (e.g., Parkinson's, type 2 diabetes).

Concluding Notes

  • Overall, caffeine is considered relatively safe; interactions with other variables are still being researched.

Origin Source
  • Caffeine is a methylxanthine, an alkaloid from plant origins.

  • Common sources include coffee, tea, and chocolate with varying caffeine concentrations.

Production Uses
  • Information on specific production uses is not detailed in the provided notes.

Benefits
  • Potential benefits include prevention of certain diseases (e.g., Parkinson's, type 2 diabetes).

Administration
  • Information on specific administration methods is not detailed in the provided notes, though it is consumed through common sources like coffee, tea, and chocolate.

Mechanism of Action
  • Mechanisms of action:

    • Inhibition of phosphodiesterase.

    • Release of calcium from stores.

    • Antagonism of adenosine receptors (primary action).

  • Caffeine leads to increased dopamine levels but may impact receptor efficiency at high doses.

Pharmacokinetics
  • Absorption: Rapid, peak concentrations in 15-45 minutes.

  • Distribution: Uniform throughout the body.

  • Metabolism: Primarily in the liver; excreted mostly by kidneys.

Acute Effects
  • Behavioral effects: Increased energy, alertness, and mood elevation.

  • Can impair decision-making despite increased motor performance.

Chronic Effects
  • Low to moderate caffeine intake shown not to affect reproduction or significant health outcomes.

  • Potential benefits include prevention of certain diseases (e.g., Parkinson's, type 2 diabetes).

Tolerance and Dependence
  • Tolerance develops, especially for physiological effects (renal, sleep, etc.), less for stimulant effects.

  • Withdrawal symptoms commonly include headache and fatigue.

Trends (Consumption)
  • Estimated average global consumption:  70~70 mg/day.

  • US average: nearly 170170 mg/day, rising to 186186 mg/day.

  • 9090% of the population consumes caffeine products.

Variables Impacting Use
  • Caffeine, nicotine, and alcohol commonly used together.

  • Can mask alcohol's effects, may lead to binge drinking.

  • Interactions with other variables are still being researched.